![Caren Deardorf](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Caren Deardorf
Director/Board Member at
CRINETICS PHARMACEUTICALS, INC.
Net worth: 790 099 $ as of 2026-05-30
Profile
Caren Deardorf currently works at Pan Mass Challenge, as Director, Crinetics Pharmaceuticals, Inc., as Independent Director from 2022, and Pan Massachusetts Challenge, Inc., as Secretary & Director.
Ms. Deardorf also formerly worked at Can Do Multiple Sclerosis, as Director, Neurosense Therapeutics Ltd., as Independent Director from 2021 to 2024, Editas Medicine, Inc., as Chief Commercial & Strategy Officer from 2023 to 2025, Magenta Therapeutics, Inc., as Chief Commercial Officer from 2021 to 2023, Ohana Biosciences, Inc., as Chief Commercial Officer from 2019 to 2021, and Biogen, Inc., as VP-Product Development & Commercialization from 2017 to 2019.
Ms. Deardorf received her undergraduate degree from Tufts University and Masters Business Admin degree from F.W.
Olin Graduate School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-17 | 22,225 ( 0.02% ) | 790 099 $ | 2026-05-30 |
Caren Deardorf active positions
| Companies | Position | Start |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Director/Board Member | 2022-03-10 |
Pan Mass Challenge
 Pan Mass Challenge Miscellaneous Commercial ServicesCommercial Services Provides fund raises money for life-saving cancer research and treatment | Director/Board Member | - |
Pan Massachusetts Challenge, Inc.
 Pan Massachusetts Challenge, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in raising funds for cancer research and treatment | Director/Board Member | - |
Former positions of Caren Deardorf
| Companies | Position | End |
|---|---|---|
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | 2025-03-31 |
| NEUROSENSE THERAPEUTICS LTD. | Director/Board Member | 2024-06-26 |
| MAGENTA THERAPEUTICS | Corporate Officer/Principal | 2023-02-06 |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates early stage biotechnology company | Corporate Officer/Principal | 2021-04-30 |
| BIOGEN INC. | Corporate Officer/Principal | 2018-12-31 |
Training of Caren Deardorf
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
33
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Can Do Multiple Sclerosis
 Can Do Multiple Sclerosis Miscellaneous Commercial ServicesCommercial Services Provides lifestyle empowerment programs | Commercial Services |
Pan Mass Challenge
Pan Mass Challenge Miscellaneous Commercial ServicesCommercial Services Provides fund raises money for life-saving cancer research and treatment | Commercial Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
F.W. Olin Graduate School of Business
 F.W. Olin Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Ohana Biosciences, Inc.
Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates early stage biotechnology company | Commercial Services |
Neurosense Therapeutics Ltd.
 Neurosense Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage drug development company | Health Technology |
Pan Massachusetts Challenge, Inc.
Pan Massachusetts Challenge, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in raising funds for cancer research and treatment | Commercial Services |
- Stock Market
- Insiders
- Caren Deardorf
